Atomi Financial Group, Inc. Cytosorbents Corp Put Options Transaction History
Atomi Financial Group, Inc.
- $2.65 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CTSO
# of Institutions
51Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$4.05 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.09 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$1.7 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.27 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1 Million1.64% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $34.9M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...